Intravenous cyclophosphamide in refractory polyneuropathy associated with IgM monoclonal gammopathy: An uncontrolled open trial

American Journal of Medicine

Volumn 118, Issue 4, 2005, Pages 426-430

  Hamidou, Mohamed A ^a,b   Belizna, Cristina ^a   Wiertlewsky, Sandrine ^a   Audrain, Marie ^a   Biron, Charlotte ^a   Grolleau, Jean Yves ^a   Mussini, Jean Marie ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN M; MESNA; OLASETRON; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; ELECTROPHYSIOLOGY; FEMALE; HEALTH STATUS; HUMAN; LABORATORY TEST; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MONOTHERAPY; MUSCLE STRENGTH; NERVE CONDUCTION; POLYNEUROPATHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RATING SCALE; SCORING SYSTEM; SIDE EFFECT; STATISTICAL SIGNIFICANCE; STUDENT T TEST;

EID: 16244408948     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2004.12.008     Document Type: Article

References (20)

1. B. Chassande, J.M. Leger, A.B. Younes-Chennoufi Peripheral neuropathy associated with IgM monoclonal gammopathy correlations between M-protein antibody activity and clinical/electrophysiological features in 40 cases Muscle Nerve 21 1998 55 62
2. A. Vital, A. Lagueny, J. Julien Chronic inflammatory demyelinating polyneuropathy associated with dysglobulinemia a peripheral nerve biopsy study in 18 cases Acta Neuropathol (Berl) 100 2000 63 68
3. N. Latov Prognosis of neuropathy with monoclonal gammopathy Muscle Nerve 23 2000 150 152
4. E. Nobile-Orazio, M. Carpo Neuropathy and monoclonal gammopathy Curr Opin Neurol 14 2001 615 620
5. K.C. Gorson Clinical features, evaluation and treatment of patients with polyneuropathy associated with monoclonal gammopathy of undetermined significance J Clin Apheresis 14 1999 149 153
6. M.P. Wicklund, J.T. Kissel Paraproteinemic neuropathy Curr Treat Options Neurol 3 2001 147 156
7. R.A. Kyle, T.M. Therneau, S.V. Rajkumar A long-term study of prognosis in monoclonal gammopathy of undetermined significance N Engl J Med 346 2002 564 569
8. M. Eurelings, K.G.M. Moons, N.C. Notermans Neuropathy and IgM M-proteins prognostic value of antibodies to MAG, SGPG and sulfatide Neurology 56 2001 228 233
9. E. Oksenhendler, S. Chevret, J.M. Leger Plasma exchange and chlorambucil in polyneuropathy associated with monoclonal IgM gammopathy J Neurol Neurosurg Psychiatry 59 1995 243 247
10. P.J. Dyck, P.A. Low, A.J. Windebank Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance N Engl J Med 325 1991 1482 1486
11. M.C. Dalakas, R.H. Quarles, R.G. Farrer A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy Ann Neurol 40 1996 792 795
12. X. Mariette, C. Chastang, P. Clavelou A randomized trial comparing interferon alpha and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM J Neurol Neurosurg Psychiatry 63 1997 28 34
13. X. Mariette, J.C. Brouet, S. Chevret A randomized double blind trial versus placebo does not confirm the benefit of alpha-interferon in polyneuropathy associated with monoclonal IgM J Neurol Neurosurg Psychiatry 69 2000 279 280
14. H.C. Wilson, M.P.T. Lunn, S. Schey, R.A.C. Hughes Successful treatment of IgM paraproteinaemic neuropathy with fludarabine J Neurol Neurosurg Psychiatry 66 1999 575 580
15. A. Pestronk, J. Florence, T. Miller, R. Choski, M.T. Al-Lozi, T.D. Levine Treatment of IgM antibody associated polyneuropathies using rituximab J Neurol Neurosurg Psychiatry 74 2003 485 489
16. S. Renaud, M. Gregor, P. Fuhr Rituximab in the treatment of polyneuropathy associated with anti-MAG antibodies Muscle Nerve 27 2003 611 615
17. K.C. Gorson, A.H. Ropper, D.H. Weinberg, R. Weinstein Treatment experience in patients with anti-myelin-associated glycoprotein neuropathy Muscle Nerve 24 2001 778 786
18. G. Blume, A. Pestronk, L.T. Goodnough Anti-MAG antibody-associated polyneuropathies improvement following immunotherapy with monthly plasma exchange and IV cyclophosphamide Neurology 45 1995 1577 1580
19. N.C. Notermans, H.M. Lokhorst, H. Franssen Intermittent cyclophosphamide and prednisone treatment of polyneuropathy associated with monoclonal gammopathy of undetermined significance Neurology 47 1996 1227 1233
20. E. Nobile-Orazio, N. Meucci, L. Baldini Long-term prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapies Brain 123 2000 710 717